Abstract:Background To retrospectively evaluate the added benefit of adding endobiliary radiofrequency ablation (EB-RFA) to biliary metal stent placement for patients with malignant biliary obstruction (MBO). Methods From November 2013 to June 2018, 163 patients with MBO who had undergone percutaneous EB-RFA and stent placement (RFA-stent group, n = 90) or stent placement only (Stent group, n = 73) were included. According to the causes of biliary obstruction, the two treatment groups were divided into Cholangiocarcinoma Subgroup, Pancreatic carcinoma Subgroup and Remaining disease Subgroup. Overall survival(OS), primary and secondary stent patency (PSP, SSP), complications between the two groups were compared, and the prognostic factors of OS, PSP and SSP were analyzed. Results RFA-Stent group resulted in better median OS (7.0 vs 4.5 months, P= 0.034), PSP (8.0 vs 5.1 months, P=0.003) and SSP (9.8 vs 5.1 months, P < 0.001) than Stent group (figure 1). In Cholangiocarcinoma subgroup, the median OS in two groups was 8.0 months and 4.7 months, respectively, P = 0.791; The median PSP and SSP in RFA-Stent group were longer than that Stent group( PSP: 8.0 months vs 6.0 months, P = 0.024, respectively; SSP: 9.0 months vs 6.0 months, respectively, P < 0.001) (figure 2). In Pancreatic carcinoma subgroup, RFA-Stent group resulted in better median OS (8.5 vs 4.0 months, P= 0.006), PSP (8.5 vs 4.5 months, P=0.021) and SSP (9.8 vs 4.5 months, P = 0.004) than Stent group(figure 3). There was no statistical difference in OS, PSP and SSP between the two groups in Remaining subgroup(figure 4). The complications were comparable between the two groups. Multivariate analysis showed that treatment methods, performance status score, postoperative combination therapy, obstruction etiology, obstruction location type, preoperative bilirubin level and postoperative bilirubin decreased value were independent prognostic factors for survival. Treatment methods, previous treatment for primary disease and preoperative bilirubin level were independent prognostic factors for PSP and SSP. Conclusions RFA-Stent confers therapeutic benefits in patients with unresectable MBO, especially in those patients with pancreatic carcinoma.

Endobiliary Radiofrequency Ablation for Unresectable Malignant Biliary Strictures: Survival Benefit Perspective

Effect of endoscopic radiofrequency ablation on the survival of patients with inoperable malignant biliary strictures: A large cohort study

Endoscopic Radiofrequency Ablation May Be Preferable in the Management of Malignant Biliary Obstruction: A Systematic Review and Meta‐analysis

Efficacy and safety of endoscopic radiofrequency ablation for unresectable extrahepatic cholangiocarcinoma: a randomized trial

The Safety and Efficacy of Percutaneous Intraductal Radiofrequency Ablation in Unresectable Malignant Biliary Obstruction: A Single-Institution Experience.

Percutaneous Intraductal Radiofrequency Ablation for Malignant Biliary Obstruction Caused by Recurrence and Metastasis after Primary Tumor Resection.

Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma

Endoscopic radiofrequency ablation plus plastic stent placement versus stent placement alone for unresectable extrahepatic biliary cancer: a multicenter randomized controlled trial

Local palliative therapies for unresectable malignant biliary obstruction: radiofrequency ablation combined with stent or biliary stent alone? An updated meta-analysis of nineteen trials

IDDF2019-ABS-0077 Percutaneous Endobiliary Radiofrequency Ablation and Self-Expandable Metal Stent Placement Versus Stent Placement Alone for Malignant Biliary Obstruction

Percutaneous Intraductal Radiofrequency Ablation Combined with Biliary Stent Placement for Nonresectable Malignant Biliary Obstruction Improves Stent Patency but Not Survival.

The Impact of Radiofrequency Ablation on Survival Outcomes and Stent Patency in Patients with Unresectable Cholangiocarcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Consensus Statements on Endoscopic Radiofrequency Ablation for Malignant Biliary Strictures

Improving Biliary Stent Patency for Malignant Obstructive Jaundice Using Endobiliary Radiofrequency Ablation: Experience in 150 Patients

Comparison Of Intraluminal Radiofrequency Ablation And Stents Vs. Stents Alone In The Management Of Malignant Biliary Obstruction

Impact of temperature-controlled endobiliary radiofrequency ablation for inoperable hilar cholangiocarcinoma: A propensity score-matched analysis

ENDOLUMINAL RADIOFREQUENCY ABLATION WITH STENTING VS STENTING ONLY IN PATIENTS WITH MALIGNANT BILIARY OBSTRUCTION: A META-ANALYSIS OF RANDOMISED TRIALS

Endoscopic radiofrequency biliary ablation treatment: A comprehensive review

Tu1404 Endoscopic Biliary Radiofrequency Ablation Prolong the Survival of Patients with Unrespectable Extrahepatic Cholangiocarcinoma

Clinical Efficacy and Short-term Prognosis of ERCP-guided Intracavitary Radiofrequency Ablation Combined with Stent Implantation in Treatment of Malignant Bile Duct Tumor Associated by Obstruction

Percutaneous endobiliary radiofrequency ablation and stent placement for unresectable malignant biliary obstruction: a propensity score matching retrospective study